Rang	Name	Position
1	Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.	CEO & Executive Director
2	Dr. Aradhana Sarin M.D.	CFO & Executive Director
3	Ms. Pam P. Cheng	EVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board
4	Mr. Joris Silon	Head of Investor Relations
5	Mr. Jeffrey Pott J.D.	CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board
6	Dr. Ruud Dobber Ph.D.	Executive Vice-President of BioPharmaceuticals Business Unit
7	Dr. Susan Mary Galbraith M.D., Ph.D.	Executive Vice President of Oncology R&D
8	Ms. Iskra Reic	Executive Vice President of International
9	Mr. David Fredrickson	Executive Vice-President of Oncology Haematology Business Unit
10	Ms. Ruth March FMEDSCI, O.B.E., Ph.D.	Senior VP of Precision Medicine - R&D Oncology

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Investors Finance Co PLC	0,00%	0,00 Mio. USD
2	Vanguard Capital Management, LLC	0,00%	0,00 Mio. USD
3	Capital Research & Mgmt Co - Division 3	0,00%	0,00 Mio. USD
4	FMR Inc	0,00%	0,00 Mio. USD
5	Capital World Investors	0,00%	0,00 Mio. USD
6	Legal & General Group PLC	0,00%	0,00 Mio. USD
7	Wellington Management Company LLP	0,00%	0,00 Mio. USD
8	T. Rowe Price Associates, Inc.	0,00%	0,00 Mio. USD
9	Bank of America Corp	0,00%	0,00 Mio. USD
10	JPMorgan Chase & Co	0,00%	0,00 Mio. USD
11	VANGUARD ASSET MANAGEMENT Ltd	0,00%	0,00 Mio. USD
12	PRIMECAP Management Company	0,00%	0,00 Mio. USD
13	Franklin Resources Inc	0,00%	0,00 Mio. USD
14	Amundi	0,00%	0,00 Mio. USD
15	Vanguard Fiduciary Trust Co	0,00%	0,00 Mio. USD
16	DZ BANK AG Deutsche Zentral-Genossenschaftsbank Frankfurt am Main	0,00%	0,00 Mio. USD
17	Deutsche Bank AG	0,00%	0,00 Mio. USD
18	HHG PLC	0,00%	0,00 Mio. USD
19	Aviva PLC	0,00%	0,00 Mio. USD
20	Fisher Asset Management, LLC	0,00%	0,00 Mio. USD